Summary
Fifteen vaccinia virus (VV) recombinants derived from VV strains Praha, LIVP and DD (i.e. Dryvax Wyeth vaccine - derived) and expressing genes for S, preS2-S or c antigens of hepatitis B virus (HBV) were tested in monkey CV-1 cells and human diploid LEP cells. The production of infectious virus was found to be alike in all the recombinants and parental viruses as well. However, several recombinants produced markedly lesser amounts of S and preS2 antigens in LEP cells than in CV-1 cells. This reduction was independent of the parental virus used. There was, however, a relationship between the production of preS2 in CV-1 cells and the production of S and preS2 antigens in LEP cells; in general, recombinants efficiently inducing preS2 antigen formation in CV-1 cells produced markedly reduced amounts of S and preS2 antigens in LEP cells. Reduction of HBV antigen production in LEP cells was not apparent in recombinants expressing only S or c antigens of HBV, and the production of c antigen by double recombinants was not influenced by simultaneous expression of preS2 and S. The various recombinants also differed in the ratio of S:preS2 antigen formation. This difference seemed to be associated with the length of the untranslated leader sequence preceding preS2 but not with the parental virus or cell type used. The titers of antibodies against S and preS2 antigens induced in mice immunized with different recombinants differed markedly. The differences in the ratio of S:preS2 antigen production in vitro were not reflected in vivo by S:preS2 antibody ratio.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Altstein AD, Zakharova LG, Loparev BN, Pashvykina GV, Gorodetsky SI, Chernos VI, Senkevich TG, Antonova TP, Andzhaparidze OG (1985) Generation of hepatitis virus surface antigen-inducing vaccinia virus recombinant on the basic of LIVP strain. Dokl Akad Nauk USSR 285: 696–699 (in Russian)
Altstein AD, Andzhaparidze OG, Antonova TP, Baev AA, Baisar D, Bendukidze KA, Gorodecki SI, Zacharova LG, Kriazevskaia MV, Parhvykina GV, Fodor I, Chernos VI (1986) Dual recombinant of vaccinia virus with expression of surface antigen of hepatitis virus B and thymidine kinase of herpes simplex virus. Dokl Akad Nauk USSR 289: 1493–1496 (in Russian)
Bichko V, Pushko P, Dreilina D, Pumpen P, Gren E (1985) Subtype ayw variant of hepatitis B virus. DNA primary structure analysis. FEBS Lett 185: 208–212
Burrell CJ, MacKay P, Greenaway PJ, Hofschneider PM, Murray K (1979) Expression in Escherichia coli of hepatitis B virus DNA cloned in plasmid pBR322. Nature 279: 43–47
Budkowska AA, Riottot MM, Dubreil P, Lazizi Y, Brechot CH, Sobczak E, Petit MA Pillot J (1986) Monoclonal antibody recognizing preS2 epitope and anti-preS2 antibody. J Med Virol 20: 111–125
Chelyapov NV, Antonova TP, Yanova NN, Chernos VI (1988) Antigenic properties of vaccinia virus and of the virus recombinant strains expressing heterologous genes. Acta Virol 32: 409–416
Chelyapov NV, Rakhilina LE, Antonova TP, Chernos VI, Grigoriev VG, Chudakova EA, Pashvykina GV, Zakharova LG, Altstein AD, Kutinová L, Hamšíková E, Němečková Š (1991) Two vaccinia virus recombinants expressing HBsAg with different concentration ofa and preS2 antigenic determinants. Acta Virol 35: 413–422
Cheng KCH, Smith GL, Moss B (1986) Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus. J Virol 60: 337–344
Cheng KC, Moss B (1987) Selective synthesis and secretion of particles composed of the hepatitis B virus middle surface protein directed -by a recombinant vaccinia virus: induction of antibodies to pre-S and S epitopes. J Virol 61: 1286–1290
Dubois MF, Pourcel C, Rousset S, Chay L, Tiollais P (1980) Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc Natl Acad Sci USA 77: 4549–4553
Fuerst TR, Earl PL, Moss B (1987) Use of a hybrid vaccinia virus T7 RNA polymerase systems for expression of target genes. Mol Cell Biol 7: 2538–2544
Hamsikova E, Zavadova H, Kutinova L, Ludvikova V, Krchnak V, Nemeckova S, Vonka V (1990) Priming effect of recombinant vaccinia virus coding for the middle hepatitis B surface antigen. Arch Virol 113: 283–289
Joklik WK (1962) The purification of four strains of poxvirus. Virology 18: 9–10
Kozak M (1991) Effects of long 5′ leader sequences on initiation by eukaryotic ribosomes in vitro. Gene 1: 117–125
Kutinova L, Nemeckova S, Hamsikova E, Press M, Zavadova H, Hirsch I, Němeček V, Krchnak V, Smrt J, Slonim D, Vonka V (1990) A recombinant vaccinia virus expressing hepatitis B virus middle surface proteins: restricted expression of HBV antigen in human diploid cells. Arch Virol 112: 181–193
Mackett M, Smith GL, Moss B (1984) General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol 49: 857–864
McLachlan A, Milich DR, Raney AK, Riggs MG, Hughes JL, Sorge J, Chisari FV (1987) Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J Virol 61: 683–692
Nemeckova S, Kutinova L, Hamsikova E, Kunke D, Press M, Zavadova H, Smrt J, Vonka V (1991) Synthesis and immunogenicity of hepatitis B virus envelope antigen expressed by recombinant vaccinia virus: finding of retention signal in the C-terminal portion of the pre S1 domain of subtype adyw. Arch Virol 121: 29–41
Panicali D, Paoletti E (1982) Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc Natl Acad Sci USA 79: 4927–4931
Paoletti E, Lipkinsas BR, Samsonoff C, Mercer S, Panicali D (1984) Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoproteins D. Proc Natl Acad Sci USA 81: 193–197
Pasek M, Goto T, Gilbert W, Zink B, Schaller H, MacKay P, Leadbetter G, Murray K (1979) Hepatitis B virus genes and their expression inE. coli. Nature 282: 575–579
Pashvykina GV, Zakharova LG, Piskareva LM, Chudakova EA (1990) Poxvirus recombinants expressing the surface antigen (HBsAg) of hepatitis B virus (HBV) with preS2 antigenic determinant. In: Shestakov SV, Tarassov VA (eds) Molecular mechanisms of genetic processes, vol 7. Institute of General Genetics, Moscow, p 252 (in Russian)
Perkus ME, Panicali D, Mercer S, Paoletti E (1986) Insertion and deletion mutants of vaccinia virus. Virology 152: 285–297
Pourcel C, Louise S, Gervais M, Chenciner N, Dubois MF, Tiollais P (1982) Transcription of the hepatitis B surface antigen gene in mouse transformed with cloned viral DNA. J Virol 42: 100–105
Pumpen PP, Dishler AV, Kozlovskaya TM, Bichko VV, Gren EJ, Rivkina MB, Grinberg AP, Kukain RA (1981) HBV DNA cloning inE. coli. Dokl Akad Nauk USSR 260: 1022–1024 (in Russian)
Slonim D, Hulenova M (1969) Study of plaque titration of vaccinia virus in chick embryo cell cultures. I. Assays und agar overlay. Acta Virol 13: 209–215
Smith GL, Mackett M, Moss B (1983) Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 302: 490–495
Standring DN, Ou JH, Rutter WJ (1986) Assembly of viral particles in Xenopus oocytes: pre- surface- antigens regulate secretion of the hepatitis B viral surface envelope particle. Proc Natl Acad Sci USA 83: 9338–9342
Watanabe K, Kobayashi H, Kajiyama K, Morita M, Yasuda A, Goth H, Saek IS, Saito H, Kojima A (1989) Improved recombinant LC16m0 or LC16m8 vaccinia virus successfully expressing hepatitis B surface antigen. Vaccine 7: 53–59
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kutinová, L., Němečková, Š., Hamšíková, E. et al. Hepatitis B virus proteins expressed by recombinant vaccinia viruses: influence of preS2 sequence on expression surface and nucleocapsid proteins in human diploid cells. Archives of Virology 134, 1–15 (1994). https://doi.org/10.1007/BF01379102
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01379102